Influence of Obesity on Breast Density Reduction by Omega-3 Fatty Acids: Evidence from a Randomized Clinical Trial
暂无分享,去创建一个
J. Liao | T. Hartman | H. Thompson | L. Demers | A. Manni | J. McGinley | K. El-Bayoumy | C. Aliaga | J. Richie | B. Prokopczyk | S. Schetter | N. Trushin | C. Signori | A. Calcagnotto | C. Hamilton | C. Dubrock | Narinder Sandhu
[1] J. Liao,et al. Differential impact of body mass index on absolute and percent breast density: implications regarding their use as breast cancer risk biomarkers , 2014, Breast Cancer Research and Treatment.
[2] J. Liao,et al. Influence of omega‐3 fatty acids on Tamoxifen‐induced suppression of rat mammary carcinogenesis , 2014, International journal of cancer.
[3] C. Perou,et al. Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013 , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.
[4] H. Thompson,et al. Proteomic Changes Induced by Effective Chemopreventive Ratios of n-3:n-6 Fatty Acids and Tamoxifen against MNU-Induced Mammary Cancer in the Rat , 2013, Cancer Prevention Research.
[5] C. Vachon,et al. Mammographic Breast Density Response to Aromatase Inhibition , 2013, Clinical Cancer Research.
[6] J. Russo,et al. Fish Oil Alters Tamoxifen-Modulated Expression of mRNAs That Encode Genes Related to Differentiation, Proliferation, Metastasis, and Immune Response in Rat Mammary Tumors , 2012, Nutrition and cancer.
[7] Weiqin Jiang,et al. Identification of a molecular signature underlying inhibition of mammary carcinoma growth by dietary N-3 fatty acids. , 2012, Cancer research.
[8] Woo Kyung Moon,et al. Breast density change as a predictive surrogate for response to adjuvant endocrine therapy in hormone receptor positive breast cancer , 2012, Breast Cancer Research.
[9] T. Hartman,et al. Administration of omega-3 fatty acids and Raloxifene to women at high risk of breast cancer: interim feasibility and biomarkers analysis from a clinical trial , 2012, European Journal of Clinical Nutrition.
[10] I. Romieu,et al. ω-3 and ω-6 Polyunsaturated Fatty Acid Intakes and the Risk of Breast Cancer in Mexican Women: Impact of Obesity Status , 2011, Cancer Epidemiology, Biomarkers & Prevention.
[11] J. Liao,et al. Effects of fish oil and Tamoxifen on preneoplastic lesion development and biomarkers of oxidative stress in the early stages of N-methyl-N-nitrosourea-induced rat mammary carcinogenesis. , 2011, International journal of oncology.
[12] J. Russo,et al. Chemoprevention of breast cancer by fish oil in preclinical models: trials and tribulations. , 2011, Cancer research.
[13] P. Flachs,et al. Synergistic induction of lipid catabolism and anti-inflammatory lipids in white fat of dietary obese mice in response to calorie restriction and n-3 fatty acids , 2011, Diabetologia.
[14] S. Duffy,et al. Tamoxifen-induced reduction in mammographic density and breast cancer risk reduction: a nested case-control study. , 2011, Journal of the National Cancer Institute.
[15] V. Saraswathi,et al. The role of adipose tissue in mediating the beneficial effects of dietary fish oil. , 2011, The Journal of nutritional biochemistry.
[16] Sanford Weisberg,et al. An R Companion to Applied Regression , 2010 .
[17] R. Taguchi,et al. Transgenic Restoration of Long-Chain n-3 Fatty Acids in Insulin Target Tissues Improves Resolution Capacity and Alleviates Obesity-Linked Inflammation and Insulin Resistance in High-Fat–Fed Mice , 2010, Diabetes.
[18] J. Griggs,et al. American Society of Clinical Oncology clinical practice guideline: update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] J. Philbrick,et al. Patient decisions about breast cancer chemoprevention: a systematic review and meta-analysis. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] Jennifer A. Harvey,et al. Comparing a New Volumetric Breast Density Method (VolparaTM) to Cumulus , 2010, Digital Mammography / IWDM.
[21] Joseph P. Costantino,et al. Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing Breast Cancer , 2010, Cancer Prevention Research.
[22] N. Boyd,et al. Mammographic Density Change with 1 Year of Aerobic Exercise among Postmenopausal Women: A Randomized Controlled Trial , 2010, Cancer Epidemiology, Biomarkers & Prevention.
[23] Richard D Bruggeman,et al. The Impact of Fish Oil on the Chemopreventive Efficacy of Tamoxifen against Development of N-Methyl-N-Nitrosourea–Induced Rat Mammary Carcinogenesis , 2010, Cancer Prevention Research.
[24] Erika A. Waters,et al. Prevalence of Tamoxifen Use for Breast Cancer Chemoprevention Among U.S. Women , 2010, Cancer Epidemiology, Biomarkers & Prevention.
[25] V. Arroyo,et al. Obesity‐induced insulin resistance and hepatic steatosis are alleviated by ω‐3 fatty acids: a role for resolvins and protectins , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[26] G. Ursin,et al. Postmenopausal hormone therapy with estradiol and norethisterone acetate and mammographic density: findings from a cross-sectional study among Norwegian women , 2009, Climacteric : the journal of the International Menopause Society.
[27] N. Karssemeijer,et al. Differential impact of conventional and low‐dose oral hormone therapy, tibolone and raloxifene on mammographic breast density, assessed by an automated quantitative method , 2008, BJOG : an international journal of obstetrics and gynaecology.
[28] J. Ioannidis,et al. Survival with aromatase inhibitors and inactivators versus standard hormonal therapy in advanced breast cancer: meta-analysis. , 2006, Journal of the National Cancer Institute.
[29] C. Ruxton,et al. The health benefits of omega-3 polyunsaturated fatty acids: a review of the evidence. , 2004, Journal of human nutrition and dietetics : the official journal of the British Dietetic Association.
[30] Stephen W Duffy,et al. Tamoxifen and breast density in women at increased risk of breast cancer. , 2004, Journal of the National Cancer Institute.
[31] B. Ainsworth,et al. International physical activity questionnaire: 12-country reliability and validity. , 2003, Medicine and science in sports and exercise.
[32] D. Lawlor,et al. Associations of adult measures of childhood growth with breast cancer: findings from the British Women's Heart and Health Study , 2003, British Journal of Cancer.
[33] K. Fukunaga,et al. Dietary Docosahexaenoic Acid Suppresses N-Methyl-N-Nitrosourea-Induced Mammary Carcinogenesis in Rats More Effectively Than Eicosapentaenoic Acid , 2003, Nutrition and cancer.
[34] V. Jackson,et al. Comparison of the effect of raloxifene and continuous-combined hormone therapy on mammographic breast density and breast tenderness in postmenopausal women. , 2003, American journal of obstetrics and gynecology.
[35] I. Lambrinoudaki,et al. Mammographic changes associated with raloxifene and tibolone therapy in postmenopausal women: a prospective study , 2002, Menopause.
[36] M. Freedman,et al. Digitized mammography: a clinical trial of postmenopausal women randomly assigned to receive raloxifene, estrogen, or placebo. , 2001, Journal of the National Cancer Institute.
[37] S. Cummings,et al. The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal Women: Results From the MORE Randomized Trial , 2000 .
[38] C K Redmond,et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. , 1999, Journal of the National Cancer Institute.
[39] R. Warren,et al. Mammographic patterns as a predictive biomarker of breast cancer risk: effect of tamoxifen. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[40] S. Cummings,et al. The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation. , 1999, JAMA.
[41] E. Thurfjell,et al. Perinatal characteristics and adult mammographic patterns , 1995, International journal of cancer.
[42] Beth A Reboussin,et al. Postmenopausal hormone therapy and change in mammographic density. , 2003, Journal of the National Cancer Institute.
[43] M. Noguchi,et al. Chemoprevention of DMBA-induced mammary carcinogenesis in rats by low-dose EPA and DHA. , 1997, British Journal of Cancer.
[44] W. Willett,et al. Diet, body size, and breast cancer. , 1993, Epidemiologic reviews.